Independent
Tenure on this board
5.1 yrs
Meeting calendar
CIM · Annual meeting · Wednesday, June 10, 2026
Chimera Investment Corp
3 nominees · 3 ballot items.
Election of three Class I directors; advisory vote to approve executive compensation (say-on-pay); and ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.
Market cap
$1.1B
1Y TSR
+5.7%
Board grade
B-
Record date
Apr 9, 2026
Filing
DEF 14A
Meeting concluded · Jun 10, 2026
Follow how the vote landed and what changed on Chimera Investment Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect three Class I directors: Kevin G. Chavers, Gerard Creagh, and Susan Mills, each to serve until the 2029 annual meeting.
- 2
Advisory Vote to Approve Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement.
More detail
This management proposal requests an annual, non-binding advisory vote approving the Company’s executive compensation as disclosed in the proxy materials. Management seeks shareholder approval to gauge investor support for its pay practices and to comply with SEC requirements for a say-on-pay vote. The compensation program emphasizes performance-based pay, with incentives tied to Relative ROE, Relative Economic Return, and Relative TSR, and uses balanced cash and equity awards (RSUs and PSUs) with caps, clawback policy, and stock ownership requirements. The Board recommends a vote FOR, arguing that the program aligns management’s interests with shareholders, that prior say-on-pay votes supported the program, and that the compensation committee uses an independent consultant and governance controls. Key contextual considerations include Chimera’s recent acquisition activity (e.g., HomeXpress), portfolio repositioning, and pay outcomes for 2025 that resulted in bonuses at 65–74% of target; investors may weigh whether long-term PSUs' relative metrics appropriately align incentives given the company’s strategy and sector volatility.
- 3
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
16.3 yrs
Independent
Tenure on this board
2.7 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | THORNBURG INVESTMENT MANAGEMENT INC | 6.5% | 5,476,302 | $69M |
| 2 | BlackRock, Inc. | 4.6% | 3,864,682 | $49M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.3% | 3,606,666 | $45M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 3,494,701 | $44M |
| 5 | BlackRock, Inc. | 3.1% | 2,569,527 | $32M |
| 6 | Allianz Asset Management GmbH | 2.5% | 2,127,388 | $27M |
| 7 | STATE STREET CORP | 2.2% | 1,881,646 | $24M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,616,109 | $20M |
| 9 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9% | 1,581,913 | $20M |
| 10 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 1.8% | 1,490,480 | $19M |
Peers
Nearest market capOther Real Estate sector meetings6
Upcoming shareholder meetings at Chimera Investment Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Avalonbay Communities IncAVB
Special meeting·Aug 12, 2026·$26.8B
Inpoint Commercial Real Estate Income IncICR-PA
Annual meeting·Sep 16, 2026
Service Properties TrustSVC
Annual meeting·Jun 11, 2026·$1.1B
Arbor Realty Trust IncABR
Annual meeting·May 20, 2026·$996M
Empire State Realty Trust IncESRT
Annual meeting·May 14, 2026·$995M
Marcus & Millichap IncMMI
Annual meeting·Apr 30, 2026·$1.2B
Reference
Frequently asked questions
- When is the Chimera Investment Corp 2026 annual meeting?
- Chimera Investment Corp (CIM) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
- What is the record date for the Chimera Investment Corp 2026 meeting?
- The record date for the Chimera Investment Corp 2026 meeting is Thursday, April 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Chimera Investment Corp's 2026 meeting?
- The board is presenting 3 director nominees at the Chimera Investment Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Chimera Investment Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Chimera Investment Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.